// App-Quantinova.ai

501 : Thromboembolic and Bleeding Events Following Elective Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor

Researchers

Presenter

  • Jeffrey Gollish

Principal Investigators

  • Deborah Murnaghan

  • Helen Razmjou

  • Andrea Donovan

  • Vikas Bansal

Medical Centers

  • Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Cape Verde

  • MORE Research Group, Sunnybrook Health Sciences Center, Toronto, Canada

  • Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Neonatology, Sunnybrook Health Sciences Centre, Toronto, Canada

  • Neonatology, Sunnybrook Health Sciences Centre, Toronto, Canada

Locations

  • Cape Verde

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved